A versatile, hardy probiotic strain that reduces intestinal gas, supports iron absorption, and maintains barrier function.
What it is
Lactobacillus plantarum (Lactiplantibacillus plantarum) is a versatile, highly adaptive lactic acid bacterium present in human saliva, gut mucosa, and fermented plant foods. Cultured via precision fermentation and freeze-drying, L. plantarum features an unusually large genome encoding diverse carbohydrate-utilizing enzymes. Within Velobiotics supplements, L. plantarum utilizes patented MEP lipid microencapsulation, shielding cells against gastric acidity and bile salts for targeted colonic colonization.
Also known as: L. plantarum, Lactiplantibacillus plantarum
What it does
- Significantly reduces abdominal pain, gas, and digestive bloating.
- Enhances non-heme iron absorption by reducing intestinal ferric ions.
- Strengthens gut epithelial barrier and mucin gene expression.
- Produces plantaricin bacteriocins that suppress opportunistic pathogens.
Amplified by probiotics
Lactobacillus plantarum is a metabolic powerhouse in multi-strain formulations. Its broad enzymatic capability allows it to ferment complex plant polyphenols and dietary fibers, generating lactate, acetate, and bioactive phenolic acids. These metabolites lower intestinal pH and nourish native butyrate-producing species via cross-feeding mechanisms. L. plantarum produces ferric reductase enzymes that convert dietary ferric iron into the easily absorbable ferrous form, markedly boosting iron bioavailability. Furthermore, L. plantarum secretes plantaricin bacteriocins that suppress pathogenic microflora without harming beneficial Bifidobacteria. Protected by Velobiotics MEP microencapsulation against gastric fluid, L. plantarum adheres firmly to enterocytes, upregulating tight junction proteins and protecting intestinal barrier integrity.
Typical dose
1–20 billion CFU/day
The evidence
Evidence: strongExtensive human clinical trials demonstrate that Lactobacillus plantarum significantly reduces abdominal pain, bloating, and gas in individuals with irritable bowel syndrome. Clinical studies also confirm its ability to increase non-heme iron absorption by over 50% in human subjects. (Saleh SE 2026, Sci Rep) (Palika R 2026, Eur J Clin Nutr) (Chen K 2026, Eur J Nutr)
- Saleh SE, et al. Effects of probiotic supplementation on disease progression in patients with moderate to severe chronic kidney disease: a randomized controlled trial. Sci Rep. 2026;16: PubMed ↗
- Palika R, et al. Effect of combined probiotic and iron-folic acid supplementation on iron status and gut inflammation markers: a randomized controlled trial among anaemic children. Eur J Clin Nutr. 2026;80:594-602 PubMed ↗
- Chen K, et al. Probiotic modulation of gut microbiota with Bifidobacterium animalis subsp. lactis XLTG11 and Lactobacillus plantarum CCFM8661 mitigates recurrent respiratory infections in children: a randomised-controlled trial. Eur J Nutr. 2026;65: PubMed ↗
Safety & who should check first
Lactobacillus plantarum is widely acknowledged as safe (GRAS) with a decades-long history of safe use in food and dietary supplements. It is well tolerated without significant adverse events.